Last 12 months
Inside the activity.
10 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 4 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 24, 2024 Filed May 30, 2024 01:25 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
OtherStock Option (right to buy) · Derivative | 122,358 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-24-047639 · ownership.xml · derivative · entry 2 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,881 Underlying: Common Stock · 122,358 shares Expires 2033-12-15 F2 · kind: On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer. Read SEC document |
| May 24, 2024 Filed May 30, 2024 01:25 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 122,358 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-24-047639 · ownership.xml · derivative · entry 1 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,239 Underlying: Common Stock · 122,358 shares Expires 2033-12-15 F1 · kind: On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 122,358 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares. Read SEC document |
| May 24, 2024 Filed May 30, 2024 01:24 UTC |
GLASSPOOL JOHNDirector
|
OtherStock Option (right to buy) · Derivative | 20,976 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-24-047636 · ownership.xml · derivative · entry 2 GLASSPOOL JOHN · CIK 0001644079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,522 Underlying: Common Stock · 20,976 shares Expires 2033-12-15 F2 · kind: On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer. Read SEC document |
| May 24, 2024 Filed May 30, 2024 01:24 UTC |
GLASSPOOL JOHNDirector
|
GrantStock Option (right to buy) · Derivative | 20,976 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-24-047636 · ownership.xml · derivative · entry 1 GLASSPOOL JOHN · CIK 0001644079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,498 Underlying: Common Stock · 20,976 shares Expires 2033-12-15 F1 · kind: On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 20,976 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares. Read SEC document |
| May 24, 2024 Filed May 30, 2024 01:24 UTC |
Fedeli FabianaDirector
|
OtherStock Option (right to buy) · Derivative | 20,976 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-24-047635 · ownership.xml · derivative · entry 2 Fedeli Fabiana · CIK 0001961902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,522 Underlying: Common Stock · 20,976 shares Expires 2033-12-15 F2 · kind: On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer. Read SEC document |
| May 24, 2024 Filed May 30, 2024 01:24 UTC |
Fedeli FabianaDirector
|
GrantStock Option (right to buy) · Derivative | 20,976 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-24-047635 · ownership.xml · derivative · entry 1 Fedeli Fabiana · CIK 0001961902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,498 Underlying: Common Stock · 20,976 shares Expires 2033-12-15 F1 · kind: On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 20,976 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares. Read SEC document |
| May 24, 2024 Filed May 30, 2024 01:23 UTC |
Ence ChuckCA and CO
|
OtherStock Option (right to buy) · Derivative | 54,624 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-24-047633 · ownership.xml · derivative · entry 2 Ence Chuck · CIK 0001697779 · CA and CO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,090 Underlying: Common Stock · 54,624 shares Expires 2033-12-15 F2 · kind: On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer. Read SEC document |
| May 24, 2024 Filed May 30, 2024 01:23 UTC |
Ence ChuckCA and CO
|
GrantStock Option (right to buy) · Derivative | 54,624 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-24-047633 · ownership.xml · derivative · entry 1 Ence Chuck · CIK 0001697779 · CA and CO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,714 Underlying: Common Stock · 54,624 shares Expires 2033-12-15 F1 · kind: On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 54,624 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares. Read SEC document |
| January 31, 2024 Filed Jan 31, 2024 18:28 UTC |
Shenouda MagedChief Financial Officer
|
PurchaseCommon Stock | 6,875 | $4.06 | $27,943.44 |
DisclosureSEC source: 0001213900-24-008559 · ownership.xml · nonDerivative · entry 3 Shenouda Maged · CIK 0001658369 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,903 F1 · shares: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. F4 · price: Purchase prices range from $3.95 to $4.18 per share, inclusive. Read SEC document |
| January 31, 2024 Filed Jan 31, 2024 23:29 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
PurchaseCommon Stock | 27,460 | $4.00 | $109,752.13 |
DisclosureSEC source: 0001213900-24-008560 · ownership.xml · nonDerivative · entry 3 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,024 F1 · shares: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. F4 · price: Purchase prices range from $3.95 to $4.05 per share, inclusive. Read SEC document |
| January 31, 2024 Filed Jan 31, 2024 23:28 UTC |
Ence ChuckCA and CO
|
PurchaseCommon Stock | 13,670 | $4.05 | $55,429.12 |
DisclosureSEC source: 0001213900-24-008557 · ownership.xml · nonDerivative · entry 3 Ence Chuck · CIK 0001697779 · CA and CO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,970 F1 · shares: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. F4 · price: Purchase prices range from $3.93 to $4.17 per share, inclusive. Read SEC document |
| January 30, 2024 Filed Jan 31, 2024 18:28 UTC |
Shenouda MagedChief Financial Officer
|
PurchaseCommon Stock | 15,000 | $3.89 | $58,323.00 |
DisclosureSEC source: 0001213900-24-008559 · ownership.xml · nonDerivative · entry 2 Shenouda Maged · CIK 0001658369 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,028 F1 · shares: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. F3 · price: Purchase prices range from $3.82 to $3.90 per share, inclusive. Read SEC document |
| January 30, 2024 Filed Jan 31, 2024 23:29 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
PurchaseCommon Stock | 40,999 | $3.90 | $159,949.40 |
DisclosureSEC source: 0001213900-24-008560 · ownership.xml · nonDerivative · entry 2 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,564 F1 · shares: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. F3 · price: Purchase prices range from $3.88 to $3.97 per share, inclusive. Read SEC document |
| January 30, 2024 Filed Jan 31, 2024 23:28 UTC |
Ence ChuckCA and CO
|
PurchaseCommon Stock | 14,500 | $3.87 | $56,052.65 |
DisclosureSEC source: 0001213900-24-008557 · ownership.xml · nonDerivative · entry 2 Ence Chuck · CIK 0001697779 · CA and CO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,300 F1 · shares: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. F3 · price: Purchase prices range from $3.755 to $3.99 per share, inclusive. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 18:28 UTC |
Shenouda MagedChief Financial Officer
|
PurchaseCommon Stock | 10,800 | $3.65 | $39,450.24 |
DisclosureSEC source: 0001213900-24-008559 · ownership.xml · nonDerivative · entry 1 Shenouda Maged · CIK 0001658369 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,028 F1 · shares: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. F2 · price: Purchase prices range from $3.57 to $3.745 per share, inclusive. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 23:29 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
PurchaseCommon Stock | 31,541 | $3.71 | $117,036.03 |
DisclosureSEC source: 0001213900-24-008560 · ownership.xml · nonDerivative · entry 1 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,565 F1 · shares: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. F2 · price: Purchase prices range from $3.69 to $3.75 per share, inclusive. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 23:28 UTC |
Ence ChuckCA and CO
|
PurchaseCommon Stock | 10,800 | $3.65 | $39,438.36 |
DisclosureSEC source: 0001213900-24-008557 · ownership.xml · nonDerivative · entry 1 Ence Chuck · CIK 0001697779 · CA and CO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,800 F1 · shares: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. F2 · price: Purchase prices range from $3.585 to $3.73 per share, inclusive. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 22:26 UTC |
CASAMENTO CHARLES JDirector
|
GrantStock Option (right to buy) · Derivative | 31,522 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-23-097024 · ownership.xml · derivative · entry 1 CASAMENTO CHARLES J · CIK 0001117167 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,522 Underlying: Common Stock · 31,522 shares Expires 2033-12-15 F1 · derivative.exercise_date: The option vests in 16 equal quarterly installments commencing on March 15, 2024. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 17:28 UTC |
Shenouda MagedChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 82,090 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-23-097031 · ownership.xml · derivative · entry 1 Shenouda Maged · CIK 0001658369 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,090 Underlying: Common Stock · 82,090 shares Expires 2033-12-15 F1 · derivative.exercise_date: The options vest in 16 equal quarterly installments commencing on March 15, 2024. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 17:28 UTC |
Kelly Paul EdwardDirector
|
GrantStock Option (right to buy) · Derivative | 65,672 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-23-097029 · ownership.xml · derivative · entry 1 Kelly Paul Edward · CIK 0001658544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,672 Underlying: Common Stock · 65,672 shares Expires 2033-12-15 F1 · derivative.exercise_date: The option vests in 16 equal quarterly installments commencing on March 15, 2024. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 22:28 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 183,881 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-23-097032 · ownership.xml · derivative · entry 1 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,881 Underlying: Common Stock · 183,881 shares Expires 2033-12-15 F1 · derivative.exercise_date: The options vest in 16 equal quarterly installments commencing on March 15, 2024. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 22:27 UTC |
GLASSPOOL JOHNDirector
|
GrantStock Option (right to buy) · Derivative | 31,522 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-23-097028 · ownership.xml · derivative · entry 1 GLASSPOOL JOHN · CIK 0001644079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,522 Underlying: Common Stock · 31,522 shares Expires 2033-12-15 F1 · derivative.exercise_date: The option vests in 16 equal quarterly installments commencing on March 15, 2024. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 22:27 UTC |
Fedeli FabianaDirector
|
GrantStock Option (right to buy) · Derivative | 31,522 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-23-097027 · ownership.xml · derivative · entry 1 Fedeli Fabiana · CIK 0001961902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,522 Underlying: Common Stock · 31,522 shares Expires 2033-12-15 F1 · derivative.exercise_date: The option vests in 16 equal quarterly installments commencing on March 15, 2024. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 22:27 UTC |
Ence ChuckChief Accounting and CO
|
GrantStock Option (right to buy) · Derivative | 82,090 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001213900-23-097026 · ownership.xml · derivative · entry 1 Ence Chuck · CIK 0001697779 · Chief Accounting and CO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,090 Underlying: Common Stock · 82,090 shares Expires 2033-12-15 F1 · derivative.exercise_date: The options vest in 16 equal quarterly installments commencing on March 15, 2024. Read SEC document |
| May 25, 2023 Filed May 30, 2023 21:05 UTC |
CASAMENTO CHARLES JDirector
|
GrantStock Option (right to buy) · Derivative | 92,958 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-23-044079 · ownership.xml · derivative · entry 1 CASAMENTO CHARLES J · CIK 0001117167 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 92,958 shares Expires 2032-12-16 F1 · date: The option grant was approved by the Board of Directors of the Company on December 16, 2022, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the "Plan"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders. F2 · derivative.exercise_date: The option vests in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| May 25, 2023 Filed May 30, 2023 17:09 UTC |
Shenouda MagedChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 317,643 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-23-044089 · ownership.xml · derivative · entry 1 Shenouda Maged · CIK 0001658369 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 512,560 Underlying: Common Stock · 317,643 shares Expires 2032-12-16 F1 · date: The option grant was approved by the Board of Directors of the Company on December 16, 2022, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the "Plan"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders. F2 · derivative.exercise_date: 62,560 of the options immediately vested; 450,000 options vest in 16 equal quarterly installments commencing on March 16, 2023. F2 · balance_after: 62,560 of the options immediately vested; 450,000 options vest in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| May 25, 2023 Filed May 30, 2023 17:08 UTC |
Kelly Paul EdwardDirector
|
GrantStock Option (right to buy) · Derivative | 92,958 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-23-044087 · ownership.xml · derivative · entry 1 Kelly Paul Edward · CIK 0001658544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 92,958 shares Expires 2032-12-16 F1 · date: The option grant was approved by the Board of Directors of the Company on December 16, 2022, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the "Plan"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders. F2 · derivative.exercise_date: The option vests in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| May 25, 2023 Filed May 30, 2023 21:10 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 527,211 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-23-044093 · ownership.xml · derivative · entry 1 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 850,728 Underlying: Common Stock · 527,211 shares Expires 2032-12-16 F1 · date: The option grant was approved by the Board of Directors of the Company on December 16, 2022, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the "Plan"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders. F2 · derivative.exercise_date: 80,728 of the options immediately vested; 770,000 options vest in 16 equal quarterly installments commencing on March 16, 2023. F2 · balance_after: 80,728 of the options immediately vested; 770,000 options vest in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| May 25, 2023 Filed May 30, 2023 21:09 UTC |
SCHMIDT ERIC THOMASDirector
|
GrantStock Option (right to buy) · Derivative | 92,958 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-23-044088 · ownership.xml · derivative · entry 1 SCHMIDT ERIC THOMAS · CIK 0001754403 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 92,958 shares Expires 2032-12-16 F1 · date: The option grant was approved by the Board of Directors of the Company on December 16, 2022, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the "Plan"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders. F2 · derivative.exercise_date: The option vests in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| May 25, 2023 Filed May 30, 2023 21:08 UTC |
GLASSPOOL JOHNDirector
|
GrantStock Option (right to buy) · Derivative | 92,958 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-23-044084 · ownership.xml · derivative · entry 1 GLASSPOOL JOHN · CIK 0001644079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 92,958 shares Expires 2032-12-16 F1 · date: The option grant was approved by the Board of Directors of the Company on December 16, 2022, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the "Plan"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders. F2 · derivative.exercise_date: The option vests in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| May 25, 2023 Filed May 30, 2023 21:06 UTC |
Fedeli FabianaDirector
|
GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $4.22 | $0.00 |
DisclosureSEC source: 0001213900-23-044083 · ownership.xml · derivative · entry 1 Fedeli Fabiana · CIK 0001961902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2033-01-12 F1 · date: The option grant was approved by the Board of Directors of the Company on January 12, 2023, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the "Plan"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders. F2 · derivative.exercise_date: 25% of the option vests on the first anniversary of the date grant and the remaining 75% in equal increments of 6.25% of the total options at the end of each three-month interval over the following three year period. Read SEC document |
| May 25, 2023 Filed May 30, 2023 21:06 UTC |
Ence ChuckCA and CO
|
GrantStock Option (right to buy) · Derivative | 321,238 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-23-044081 · ownership.xml · derivative · entry 1 Ence Chuck · CIK 0001697779 · CA and CO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 518,361 Underlying: Common Stock · 321,238 shares Expires 2032-12-16 F1 · date: The option grant was approved by the Board of Directors of the Company on December 16, 2022, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the "Plan"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders. F2 · derivative.exercise_date: 18,361 of the options immediately vested; 500,000 options vest in 16 equal quarterly installments commencing on March 16, 2023. F2 · balance_after: 18,361 of the options immediately vested; 500,000 options vest in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| May 23, 2023 Filed May 24, 2023 13:00 UTC |
O'Gorman CedricChief Medical Officer
|
PurchaseCommon Stock | 10,000 | $3.18 | $31,800.00 |
DisclosureSEC source: 0001213900-23-042554 · ownership.xml · nonDerivative · entry 1 O'Gorman Cedric · CIK 0001962179 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,121 F1 · shares: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. F2 · price: Purchase prices range from $3.135 to $3.2096 per share, inclusive. Read SEC document |
| January 06, 2023 Filed Jan 13, 2023 22:54 UTC |
O'Gorman CedricChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0001213900-23-002871 · ownership.xml · derivative · entry 1 O'Gorman Cedric · CIK 0001962179 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common stock · 400,000 shares Expires 2033-01-06 F1 · derivative.exercise_date: The shares vest in 16 equal quarterly installments commencing on April 6, 2023. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 22:30 UTC |
CASAMENTO CHARLES JDirector
|
GrantStock Option (right to buy) · Derivative | 57,042 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-22-081473 · ownership.xml · derivative · entry 1 CASAMENTO CHARLES J · CIK 0001117167 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,042 Underlying: Common Stock · 57,042 shares Expires 2032-12-16 F1 · derivative.exercise_date: The option vests in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 19:31 UTC | OtherStock Option (right to buy) · Derivative | 200,000 | Not disclosed Strike: $19.03 | Not disclosed |
DisclosureSEC source: 0001213900-22-081519 · ownership.xml · derivative · entry 1 Shenouda Maged · CIK 0001658369 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 200,000 shares Expires 2031-12-17 F1 · kind: Represents the termination of milestone-based stock options granted to the reporting person on May 25, 2022, that were eligible to vest based on achievement of certain corporate objectives by the Issuer. Upon grant, the target vesting amount was reported in Table II of Form 4. On December 16, 2022, the Board of Directors determined that such milestone objectives were not achieved by the Issuer and that all 200,000 options would be terminated. F1 · shares: Represents the termination of milestone-based stock options granted to the reporting person on May 25, 2022, that were eligible to vest based on achievement of certain corporate objectives by the Issuer. Upon grant, the target vesting amount was reported in Table II of Form 4. On December 16, 2022, the Board of Directors determined that such milestone objectives were not achieved by the Issuer and that all 200,000 options would be terminated. F2 · price: Not applicable. F2 · derivative.exercise_date: Not applicable. F3 · derivative.expiration_date: Original expiration date. Read SEC document |
|
| December 16, 2022 Filed Dec 20, 2022 17:34 UTC |
Shenouda MagedChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 194,917 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-22-081479 · ownership.xml · derivative · entry 1 Shenouda Maged · CIK 0001658369 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,917 Underlying: Common Stock · 194,917 shares Expires 2032-12-16 F1 · derivative.exercise_date: 62,560 of the shares are immediately vested; 132,357 shares vest in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 17:32 UTC |
Kelly Paul EdwardDirector
|
GrantStock Option (right to buy) · Derivative | 57,042 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-22-081477 · ownership.xml · derivative · entry 1 Kelly Paul Edward · CIK 0001658544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,042 Underlying: Common Stock · 57,042 shares Expires 2032-12-16 F1 · derivative.exercise_date: The option vests in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| December 16, 2022 Filed Dec 21, 2022 00:31 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
OtherStock Option (right to buy) · Derivative | 300,000 | Not disclosed Strike: $19.03 | Not disclosed |
DisclosureSEC source: 0001213900-22-081520 · ownership.xml · derivative · entry 1 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 300,000 shares Expires 2031-12-17 F1 · kind: Represents the termination of milestone-based stock options granted to the reporting person on May 25, 2022, that were eligible to vest based on achievement of certain corporate objectives by the Issuer. Upon grant, the target vesting amount was reported in Table II of Form 4. On December 16, 2022, the Board of Directors determined that such milestone objectives were not achieved by the Issuer and that all 300,000 options would be terminated. F1 · shares: Represents the termination of milestone-based stock options granted to the reporting person on May 25, 2022, that were eligible to vest based on achievement of certain corporate objectives by the Issuer. Upon grant, the target vesting amount was reported in Table II of Form 4. On December 16, 2022, the Board of Directors determined that such milestone objectives were not achieved by the Issuer and that all 300,000 options would be terminated. F2 · price: Not applicable. F2 · derivative.exercise_date: Not applicable. F3 · derivative.expiration_date: Original expiration date. Read SEC document |
| December 16, 2022 Filed Dec 21, 2022 00:30 UTC |
Ence ChuckCA and Compliance Officer
|
OtherStock Option (right to buy) · Derivative | 200,000 | Not disclosed Strike: $19.03 | Not disclosed |
DisclosureSEC source: 0001213900-22-081518 · ownership.xml · derivative · entry 1 Ence Chuck · CIK 0001697779 · CA and Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 200,000 shares Expires 2031-12-17 F1 · kind: Represents the termination of milestone-based stock options granted to the reporting person on May 25, 2022, that were eligible to vest based on achievement of certain corporate objectives by the Issuer. Upon grant, the target vesting amount was reported in Table II of Form 4. On December 16, 2022, the Board of Directors determined that such milestone objectives were not achieved by the Issuer and that all 200,000 options would be terminated. F1 · shares: Represents the termination of milestone-based stock options granted to the reporting person on May 25, 2022, that were eligible to vest based on achievement of certain corporate objectives by the Issuer. Upon grant, the target vesting amount was reported in Table II of Form 4. On December 16, 2022, the Board of Directors determined that such milestone objectives were not achieved by the Issuer and that all 200,000 options would be terminated. F2 · price: Not applicable. F2 · derivative.exercise_date: Not applicable. F3 · derivative.expiration_date: Original expiration date. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 22:34 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 323,517 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-22-081481 · ownership.xml · derivative · entry 1 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,517 Underlying: Common Stock · 323,517 shares Expires 2032-12-16 F1 · derivative.exercise_date: 80,728 of the shares are immediately vested; 242,789 shares vest in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 22:33 UTC |
SCHMIDT ERIC THOMASDirector
|
GrantStock Option (right to buy) · Derivative | 57,042 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-22-081478 · ownership.xml · derivative · entry 1 SCHMIDT ERIC THOMAS · CIK 0001754403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,042 Underlying: Common Stock · 57,042 shares Expires 2032-12-16 F1 · derivative.exercise_date: The option vests in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 22:32 UTC |
GLASSPOOL JOHNDirector
|
GrantStock Option (right to buy) · Derivative | 57,042 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-22-081475 · ownership.xml · derivative · entry 1 GLASSPOOL JOHN · CIK 0001644079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,042 Underlying: Common Stock · 57,042 shares Expires 2032-12-16 F1 · derivative.exercise_date: The option vests in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 22:31 UTC |
Ence ChuckCA and CO
|
GrantStock Option (right to buy) · Derivative | 197,123 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001213900-22-081474 · ownership.xml · derivative · entry 1 Ence Chuck · CIK 0001697779 · CA and CO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,123 Underlying: Common Stock · 196,123 shares Expires 2032-12-16 F1 · derivative.exercise_date: 18,361 of the shares are immediately vested; 178,762 shares vest in 16 equal quarterly installments commencing on March 16, 2023. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:00 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
PurchaseCommon Stock | 55,250 | $2.10 | $115,804.00 |
DisclosureSEC source: 0001213900-22-079244 · ownership.xml · nonDerivative · entry 1 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,024 F1 · shares: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. F2 · price: Purchase prices range from $2.05 to $2.13 per share, inclusive. Read SEC document |
| September 28, 2022 Filed Feb 6, 2023 22:39 UTC Amendment |
TRAVERSA SERGIODirector · CEO
|
GiftStock Option (right to buy) · Derivative | 87,500 | $0.00 Strike: $33.43 | $0.00 |
DisclosureSEC source: 0001213900-23-008514 · ownership.xml · derivative · entry 7 TRAVERSA SERGIO · CIK 0001565832 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,500 Underlying: Common Stock · 87,500 shares Expires 2031-01-07 F1 · kind: Represents a bona fide gift of stock options to a family trust. An independent trustee is trustee of the trust. F7 · derivative.exercise_date: The options were granted on January 7, 2021. 25% of the options vested one year from the grant date, and thereafter in equal quarterly increments of 6.25% over the following three years. Read SEC document |
| September 28, 2022 Filed Feb 6, 2023 22:39 UTC Amendment |
TRAVERSA SERGIODirector · CEO
|
GiftStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $33.43 | $0.00 |
DisclosureSEC source: 0001213900-23-008514 · ownership.xml · derivative · entry 6 TRAVERSA SERGIO · CIK 0001565832 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,500 Underlying: Common Stock · 62,500 shares Expires 2031-01-07 F1 · kind: Represents a bona fide gift of stock options to a family trust. An independent trustee is trustee of the trust. F6 · derivative.exercise_date: The options were granted on January 7, 2021. 6.25% of the options vest each quarter from the date of grant. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:30 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,755 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001213900-22-037231 · ownership.xml · derivative · entry 9 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,755 shares Expires 2022-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 reflects the exercise of stock options set to expire on July 10, 2022. F8 · derivative.exercise_date: The options were granted on July 10, 2012 (the "Grant Date"). 25% of the options vested upon the Grant Date and the remaining 75% of the options vested in equal quarterly increments over the next four (4) years, so that the last set of options vested in July 2016. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:30 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
SaleCommon Stock | 4,068 | $18.32 | $74,525.76 |
DisclosureSEC source: 0001213900-22-037231 · ownership.xml · nonDerivative · entry 7 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,774 F2 · shares: The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. F7 · price: Sales prices range from $18.26 to $18.44 per share, inclusive. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:30 UTC |
TRAVERSA SERGIODirector · Chief Executive Officer
|
SaleCommon Stock | 8,848 | $18.45 | $163,245.60 |
DisclosureSEC source: 0001213900-22-037231 · ownership.xml · nonDerivative · entry 6 TRAVERSA SERGIO · CIK 0001565832 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,842 F2 · shares: The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. F6 · price: Sales prices range from $18.45 to $18.47 per share, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.